Cancer Genetics and Epigenetics 2024, Vol.12, No.6, 346-357 http://medscipublisher.com/index.php/cge 356 Szparecki G., Ilczuk T., Wołosz D., Otto W., Gornicka B., and Wolińska E., 2016, The expression of DNA methyltransferase DNMT3a in classical and fibrolamellar hepatocellular carcinoma, Experimental Pathology, 6(3): 1-4. https://doi.org/10.4172/2161-0681.1000282 Song D.L., Zhou Z.Y., Wu J., Wei T., Zhao G., Ren H., and Zhang B.X., 2022, DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma, Frontiers in Oncology, 12: 877817. https://doi.org/10.3389/fonc.2022.877817 PMID: 36091162 PMCID: PMC9459088 Takeshima H., Wakabayashi M., Hattori N., Yamashita S., and Ushijima T., 2015, Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy, Carcinogenesis, 36(2): 192-201. https://doi.org/10.1093/carcin/bgu238 PMID: 25477340 Tu J., Liao J.Y., Luk A.C.S., Tang N.L.S., Chan W.Y., and Lee T., 2015, MicroRNAs mediated targeting on the Yin-yang dynamics of DNA methylation in disease and development, The International Journal of Biochemistry and Cell Biology, 67: 115-120 https://doi.org/10.1016/j.biocel.2015.05.002 PMID: 25979370 Wu D.M., Zheng Z.H., Zhang Y.B., Fan S.H., Zhang Z.F., Wang Y.J., Zheng Y.L., and Lu J., 2019, Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells, Journal of Experimental and Clinical Cancer Research, 38(1): 237. https://doi.org/10.1186/s13046-019-1239-3 PMID: 31171015 PMCID: PMC6554918 Wang X., Cheng Y., Yan L.L., An R., Wang X.Y., and Wang H.Y., 2020, Exploring DNA methylation profiles altered in cryptogenic hepatocellular carcinomas by high-throughput targeted DNA methylation sequencing: a preliminary study for cryptogenic hepatocellular carcinoma, OncoTargets and Therapy, 13: 9901-9916 https://doi.org/10.2147/OTT.S267812 Wu J.E., Wu Y.Y., Tung C.H., Tsai Y., Chen H., Chen Y., and Hong T., 2020, DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression, Theranostics, 10(19): 8903-8923. https://doi.org/10.7150/thno.45785 Wei D.S., Yu G.M., and Zhao Y.P., 2019, MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a, OncoTargets and Therapy, 12: 7015-7024. https://doi.org/10.2147/OTT.S213583 Yan F., Shen N., Pang J.X., Molina J., Yang P., and Liu S., 2015, The DNA methyltransferase DNMT1 and tyrosine-protein kinase KIT cooperatively promote resistance to 5-Aza-2′-deoxycytidine (Decitabine) and midostaurin (PKC412) in lung cancer cells, The Journal of Biological Chemistry, 290(30): 18480-18494. https://doi.org/10.1074/jbc.M114.633693 Yan Q., Tang Y., He F., Xue J., Zhou R.S., Zhang X.Y., Luo H.Y., Zhou D.H., and Wang X.W., 2021, Global analysis of DNA methylation in hepatocellular carcinoma via a whole-genome bisulfite sequencing approach, Genomics, 113(6): 3618-3634. https://doi.org/10.1016/j.ygeno.2021.08.024 Yuan S.X., Zhang J., Xu Q.G., Yang Y., and Zhou W.P., 2016, Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma, Cancer Letters, 379(2): 239-244. https://doi.org/10.1016/j.canlet.2015.08.008 Yuan X.D., Wang J.W., Fang Y., Qian Y., Gao S., Fan Y.C., and Wang K., 2020, Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression, Pathology, Research and Practice, 216(5): 152914. https://doi.org/10.1016/j.prp.2020.152914 Yang Z., Xu F., Teschendorff A.E., Zhao Y., Yao L., Li J., and He Y.G., 2022, Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation, Frontiers in Molecular Biosciences, 9: 1067406. https://doi.org/10.3389/fmolb.2022.1067406 Zheng Y.F., Lu X.J., Zhang X.Y., and Guan B.G., 2018, The landscape of DNA methylation in hepatocellular carcinoma, Journal of Cellular Physiology, 234(3): 2631-2638. https://doi.org/10.1002/jcp.27077 Zhang C., Li J.Y., Huang T., Duan S.W., Dai D.J., Jiang D.J., Sui X.B., Li D., Chen Y.D., Ding F., Huang C.X., Chen G.Y., and Wang K.F., 2016, Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma, Oncotarget, 7(49): 81255-81267. https://doi.org/10.18632/oncotarget.13221 Zhang X.L., Liu S., Shen C.L., Wu Y.L., Zhang L., Chen X.M., and Lu F.M., 2015, DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinoma, Epigenomics, 7(4): 581-592. https://doi.org/10.2217/epi.15.23 PMID: 25815780 Zhou J.Y., 2024, The application of genomics in personalized cancer therapy, Cancer Genetics and Epigenetics, 12(1): 66-74. https://doi.org/10.5376/cge.2024.12.0009
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==